Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.

"Declaration of Competing Interest: ZW reports being named as co-inventor on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics. ZW reports being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Cleveland Heart Lab, and Procter & Gamble. All the other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

"This research was in part supported by the NIH including NIA R01 AG056653 (RMV), NIAAA R24 AA026801 (A.K.), NIAAA P50 AA024333 (J.M.B.), NHBLI R01 HL130819 (ZW), NHBLI P01 HL147823 (JMB), and NIDDK R01 DK120679 (JMB), and NIDDK R01 DK130227 (JMB). We would like to thank Mr. and Mrs. Larry Field, Mr. and Mrs. Phillip Glass, Mr. Keehn, and the Alvin Baum Family fund for their philanthropic funding. We would like to thank Christopher Strauch and Belinda Willard in the Cleveland Clinic Metabolomics core for help with quantifying short chain and branched chain fatty acids."